Caplacizumab-Yhdp Injection
47 interactions 7 cited referencesCaplacizumab-yhdp injection is used to treat acquired thrombotic thrombocytopenic purpura (aTTP; a disorder in which the body attacks itself and causes clots, low amounts of platelets and red blood cells, and could cause other serious complications) in combination with plasma exchange therapy and immunosuppressant medi… Read the full Caplacizumab-Yhdp Injection drug information page →
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Major
Caplacizumab-Yhdp Injection Ticlopidine Ticlid® An increased risk of bleeding Details Caplacizumab-Yhdp Injection Tinzaparin An increased risk of bleeding Details Caplacizumab-Yhdp Injection Tirofiban An increased risk of bleeding Details Caplacizumab-Yhdp Injection Treprostinil Orenitram An increased risk of bleeding Details Caplacizumab-Yhdp Injection Urokinase Increased risk of bleeding Details Caplacizumab-Yhdp Injection Vorapaxar Zontivity An increased risk of bleeding Details Caplacizumab-Yhdp Injection Warfarin Coumadin An increased risk of bleeding DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist